Loading provider…
Loading provider…
Pediatric Dermatology Physician in Houston, TX
NPI: 1427005453Primary Practice Location
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
6411 Fannin St, Houston, TX
Primary Employer
UT Physicians
utphysicians.com
HQ Phone
Get M.D. Adelaide's Phone Numberphone_androidMobile
Get M.D. Adelaide's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1981 - 2027
LA State Medical License
1980 - 2016
IL State Medical License
1984 - 1987

American Board of Dermatology
Dermatology

American Board of Dermatology
Pediatric Dermatology
Tulane School of Medicine
medicine.tulane.edu
Medical School
Until 1980
University of Texas Medical Branch Hospitals
Residency • Dermatology
1981 - 1984
Internship • Internal Medicine
1980 - 1981
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 97 | 177 |
| 2 | 17000Destruction of skin growth | 44 | 71 |
| 3 | 17003Destruction of 2-14 skin growths | 32 | 252 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 22 | 27 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 18 | 26 |
A review on the role of moisturizers for atopic dermatitis.
Authors: Giam, Yoke Chin, Hebert, Adelaide Ann, Dizon, Maria Victoria, Van Bever, Hugo, Tiongco-Recto, Marysia, Kim, Kyu-Han, Soebono, Hardyanto, Munasir, Zakiudin, Diana, Inne Arline, Luk, David Chi Kang
Journal: Asia Pac Allergy
Publication Date: 2016-04-28
Authors: Brian Berman, John Koo
Journal: Cutis
Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research.
Authors: Anna Pinto, Emily Germain-Lee, Ewell Roach, Bernard Cohen, Emma Kaplan
Journal: Pediatr Neurol
Publication Date: 2016-03-16
Lead Sponsor: Takeda
Intervention / Treatment: DRUG: Placebo, DRUG: Apremilast, DRUG: TAK-279
Lead Sponsor: The University of Texas Health Science Center, Houston
Intervention / Treatment: DRUG: Placebo, DRUG: SADBE 5%
Lead Sponsor: Eli Lilly and Company
Collaborators: Dermira, Inc.
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: Lebrikizumab